ERBB2 and breast cancer: These changes were accompanied by a significant improvement in the pathological diagnostic and prognostic classification of BC, which included detailed histomorphological assessment in addition to evaluation of the hormone receptor and human epidermal growth factor receptor 2 (HER2).